Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aim Immunotech Inc (AIM)

Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,118
  • Shares Outstanding, K 63,779
  • Annual Sales, $ 200 K
  • Annual Income, $ -28,960 K
  • EBIT $ -28 M
  • EBITDA $ -28 M
  • 60-Month Beta -0.36
  • Price/Sales 60.34
  • Price/Cash Flow N/A
  • Price/Book 4.29
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.47
  • Most Recent Earnings $-0.06 on 11/14/24
  • Next Earnings Date 11/15/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.09
  • Number of Estimates 1
  • High Estimate -0.09
  • Low Estimate -0.09
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +65.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1852 +2.59%
on 12/20/24
0.2440 -22.13%
on 11/27/24
-0.0100 (-5.00%)
since 11/20/24
3-Month
0.1628 +16.71%
on 11/19/24
0.2890 -34.26%
on 10/08/24
-0.0772 (-28.89%)
since 09/20/24
52-Week
0.1628 +16.71%
on 11/19/24
0.6200 -69.35%
on 04/11/24
-0.2950 (-60.82%)
since 12/20/23

Most Recent Stories

More News
AIM ImmunoTech Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

AIM ImmunoTech Inc. notified of non-compliance with NYSE American listing standards, requires plan for compliance by January 2025.Quiver AI SummaryAIM ImmunoTech Inc. announced that it has received a notice...

AIM : 0.1900 (-0.58%)
AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

AIM : 0.1900 (-0.58%)
AIM ImmunoTech Inc. Granted Patent for Ampligen® in Treatment of Post-COVID Fatigue

AIM ImmunoTech announces Netherlands patent granted for Ampligen® treatment of post-COVID fatigue, expanding its intellectual property portfolio.Quiver AI SummaryAIM ImmunoTech Inc. announced the granting...

AIM : 0.1900 (-0.58%)
AIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of Fatigue

AIM : 0.1900 (-0.58%)
AIM ImmunoTech Inc. Releases Virtual Investor Segment Featuring Dr. Charles Lapp Discussing Ampligen® and ME/CFS Research

AIM ImmunoTech released a segment featuring Dr. Charles Lapp on Ampligen®'s potential for treating Post-COVID fatigue.Quiver AI SummaryAIM ImmunoTech Inc. has released a Virtual Investor KOL Connect segment...

AIM : 0.1900 (-0.58%)
AIM ImmunoTech Participates in Virtual Investor KOL Connect Segment

AIM : 0.1900 (-0.58%)
Insider Purchase: CEO & President of $AIM (AIM) Buys 85,000 Shares

Thomas K Equels, the CEO & President of $AIM ($AIM), bought 85,000 shares of the company on 11-20-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

AIM : 0.1900 (-0.58%)
Insider Purchase: CEO & President of $AIM (AIM) Buys 60,110 Shares

Thomas K Equels, the CEO & President of $AIM ($AIM), bought 60,110 shares of the company on 11-20-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

AIM : 0.1900 (-0.58%)
AIM ImmunoTech Inc. Announces Publication of Promising Data from Roswell Park Phase 1 Study on Ampligen® for Early-Stage Triple-Negative Breast Cancer

AIM ImmunoTech announces promising Phase 1 trial results for Ampligen® in early-stage triple-negative breast cancer.Quiver AI SummaryAIM ImmunoTech Inc. announced the publication of promising data from...

AIM : 0.1900 (-0.58%)
AIM ImmunoTech Announces Publication of Breast Cancer Data from Roswell Park Comprehensive Cancer Center in The Journal for ImmunoTherapy of Cancer

AIM : 0.1900 (-0.58%)

Business Summary

AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM...

See More

Key Turning Points

3rd Resistance Point 0.2114
2nd Resistance Point 0.2052
1st Resistance Point 0.1976
Last Price 0.1900
1st Support Level 0.1838
2nd Support Level 0.1776
3rd Support Level 0.1700

See More

52-Week High 0.6200
Fibonacci 61.8% 0.4453
Fibonacci 50% 0.3914
Fibonacci 38.2% 0.3375
Last Price 0.1900
52-Week Low 0.1628

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar